Skip to main content
2026 Spine Summit Main banner

  1. Home

  • Friday, Feb 27th
    3:45 PM - 3:50 PM MST
    Genetic Determinants of Prognosis in Patients with Metastatic Non-Small Cell Lung Cancer to the Spine
    Location: Grand Saguaro North/South, Level 1
    Presenting Author: Paul McMillan Villalobos, BS – Department of Neurological Surgery, University of California, San Francisco
    Oncology
  • Saturday, Feb 28th
    7:39 AM - 7:42 AM MST
    Fusion Outcomes Following PEEK/Carbon Fiber Instrumentation and Perioperative Radiation in Oncologic Spine Surgery
    Location: Grand Canyon 9-10, Level 1
    Presenting Author: Gavril Rosoklija, MD – Albany Medical Center
    Oncology
  • Saturday, Feb 28th
    7:51 AM - 7:54 AM MST
    Retrospective Comparison of Zoledronic Acid and Denosumab for Prevention of Vertebral Compression Fractures in Multiple Myeloma
    Location: Desert Suite 3/5, Level 2
    Presenting Author: Ethan Wetzel, BS – Harvard Medical School
    Oncology
  • Saturday, Feb 28th
    7:54 AM - 7:57 AM MST
    Rethinking Blood Loss Management in Metastatic Spine Tumor Surgery: Is Tranexamic Acid Safe?
    Location: Grand Canyon 11-12, Level 1
    Presenting Author: Harsh Jain, MBBS – Vanderbilt University Medical Center
    Oncology
  • Saturday, Feb 28th
    7:57 AM - 8:00 AM MST
    Effect of Stereotactic Radiosurgery on Tumor Control and Vertebral Stability in Craniovertebral Junction Metastases
    Location: Grand Canyon 9-10, Level 1
    Presenting Author: Daniel T. Lilly, MD – Cleveland Clinic
    Oncology
  • Saturday, Feb 28th
    8:18 AM - 8:21 AM MST
    Octogenarians with Metastatic Spinal Cord Compression: Should We Operate?
    Location: Desert Suite 3/5, Level 2
    Presenting Author: Harsh Jain, MBBS – Vanderbilt University Medical Center
    Oncology
  • Sunday, Mar 1st
    7:20 AM - 7:22 AM MST
    The Impact of Lesion Size on Outcomes Following Stereotactic Radiosurgery for Spinal Metastases
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Daniel T. Lilly, MD – Cleveland Clinic
    Oncology
  • Sunday, Mar 1st
    7:24 AM - 7:26 AM MST
    Predictors of Percutaneous Pedicle Screw Fixation Failure in Cancer Patients with Pathological Vertebral Body Fractures
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Graham M. Winston, MD – Weill Cornell Department of Neurological Surgery
    Oncology
  • Sunday, Mar 1st
    7:26 AM - 7:28 AM MST
    Surgical Management of Spinal Chondrosarcomas: An Institutional Experience and Systematic Review of the Literature
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Abdul Ghaith, MD, PHD – Johns Hopkins Hospital
    Oncology
  • Sunday, Mar 1st
    7:30 AM - 7:32 AM MST
    Predictors of Kyphoplasty Failures Requiring Surgical Stabilization in Cancer Patients with Pathological Vertebral Body Fractures
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Graham M. Winston, MD – Weill Cornell Department of Neurological Surgery
    Oncology
  • Sunday, Mar 1st
    7:32 AM - 7:34 AM MST
    Survival and Molecular Predictors in Colorectal Cancer Spinal Metastases: A Retrospective Cohort Study
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Abdul Ghaith, MD, PHD – Johns Hopkins Hospital
    Oncology
  • Sunday, Mar 1st
    7:42 AM - 7:44 AM MST
    Hybrid Spine Reconstruction Using an Expandable Cage Combined with Vascularized Free Fibula Autograft After En Bloc Spondylectomy for Primary Bone Tumors of the Mobile Spine
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Laurence Rhines, MD – MD Anderson Cancer Center
    Oncology
  • Sunday, Mar 1st
    7:46 AM - 7:48 AM MST
    Long-Term Hardware Failure and Autofusion Rates for Spinal Oncology
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Luis O. Vargas, BS – Jacobs School of Medicine University at Buffalo
    Oncology
  • Sunday, Mar 1st
    7:48 AM - 7:50 AM MST
    Neurological Recovery After Metastatic Spine Tumor Surgery for Spinal Cord Compression: Can Unsupervised Machine Learning Identify Recovery Patterns?
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Clayton R. Baker, BS – Vanderbilt University School of Medicine
    Oncology
  • Sunday, Mar 1st
    7:50 AM - 7:52 AM MST
    Preoperative Radiotherapy Timing Does Not Influence Wound Complication Rates
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Hunter S. Yamada, BS – UCSF
    Oncology
  • Sunday, Mar 1st
    7:52 AM - 7:54 AM MST
    Impact of Bowel and Bladder Dysfunction on Patient Reported Outcomes in Patients Undergoing a Sacrectomy for a Primary Bone Tumor
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Raphaele Charest-Morin, MD, FRCSC – University of British Columbia
    Oncology
  • Sunday, Mar 1st
    8:02 AM - 8:04 AM MST
    Impact of Surgical Margins and Radiation Therapy on Survival in Spinal Chordoma and Chondrosarcoma: A Single-Institution Retrospective Cohort Study
    Location: Desert Suite 4/6, Level 2
    Presenting Author: William Chu Kwan, MD PhD – University of Miami
    Oncology
  • Sunday, Mar 1st
    8:08 AM - 8:10 AM MST
    Defining the Optimal Surgical Composite Outcome in Primary Malignant Bone Tumors of the Spine: International Delphi Study
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Rafael de la Garza Ramos, MD – Montefiore Einstein
    Oncology
  • Sunday, Mar 1st
    8:10 AM - 8:12 AM MST
    Does Duration of Symptoms in Metastatic Spine Disease Affect Recovery and Outcomes? A Systematic Review and Meta-Analysis
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Advith Sarikonda, BA BS – Vanderbilt University Medical Center
    Oncology
  • Sunday, Mar 1st
    8:12 AM - 8:14 AM MST
    Does preoperative embolization help to lower surgical blood loss in nonvascular metastatic spine tumor surgery?
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Hunter S. Yamada, BS – UCSF
    Oncology
  • Sunday, Mar 1st
    8:14 AM - 8:16 AM MST
    Effect of Facility Caseload on Clinical Outcomes for Primary Malignant Intramedullary Spinal Tumors
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Ataollah Shahbandi, MD – Medical College of Wisconsin
    Oncology
  • Sunday, Mar 1st
    8:16 AM - 8:18 AM MST
    En Bloc Versus Intralesional Resection in Cervical Chordoma with Sub-analysis of High Cervical Chordomas: An Institutional Experience with Systematic Review and Meta-Analysis.
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Taha Khalilullah, BS – Johns Hopkins School of Medicine
    Oncology
  • Sunday, Mar 1st
    8:24 AM - 8:26 AM MST
    Long-Term Follow-Up of Standalone Intrapelvic Fixation Post-Sacrectomy
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Gabrielle Santangelo, MD – Northwell Health
    Oncology
  • Sunday, Mar 1st
    8:32 AM - 8:34 AM MST
    Comparison of Survival, Neurological, and Radiographic Outcomes Between Corpectomy and Separation Surgery for Spinal Metastatic Disease: A Single Institutional Experience
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Clayton Rosinski, MD – University of Iowa
    Oncology
  • Sunday, Mar 1st
    8:34 AM - 8:36 AM MST
    Evaluating the Real-World Predictive Utility of Karnofsky and ECOG Performance Status for 90-Day Survival After Oncologic Surgery for Metastatic Spinal Tumors
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Rafael de la Garza Ramos, MD – Montefiore Einstein
    Oncology
  • Sunday, Mar 1st
    8:36 AM - 8:38 AM MST
    Impact of Tumor Location on Clinical Presentation and Outcomes in Spinal Ependymomas: Insights from a 17-Year Retrospective Analysis
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Abdul Ghaith, MD, PHD – Johns Hopkins Hospital
    Oncology
  • Sunday, Mar 1st
    8:42 AM - 8:44 AM MST
    Implications of 30-Day Postoperative DVT/PE on Morbidity and Mortality in Patients Undergoing Spinal Surgery for Metastatic Spinal Tumors
    Location: Desert Suite 4/6, Level 2
    Presenting Author: Apratim Maity, BS – Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
    Oncology